Delisting riskPopularity #4,237
Akari Therapeutics (ADR) (AKTX)
Develops preclinical oncology antibody-drug conjugates based on its PH1 payload platform.
$9.45
vs last close−0.60 (−5.97%)
Something off on this page? Send us feedback.
Next report
Dec 4, 26
in 72 days
EPS estimate
−$2.24
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '25May '25Aug '25Nov '25Mar '26May '26Aug '26Dec '26
Reported−$6.80−$5.40−$2.40−$4.00−$2.99−$9.74−$272.00Pending
Estimate−$40.00—−$3.60−$1.60−$1.80−$1.33−$1.04−$2.24
Surprise+83.0%—+33.3%−150.0%−66.1%−632.3%−26,053.8%—
RevenueReportedEstimate
Apr '25May '25Aug '25Nov '25Mar '26May '26Aug '26Dec '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$2.26 | — | — |
| Sep 2027 | −$2.29 | — | — |
| Jun 2027 | −$2.00 | — | — |
| Mar 2027 | −$2.09 | — | — |
| Dec 2026 | −$1.52 | — | — |
| Dec 2026 | −$2.24 | — | — |
| Aug 2026 | −$1.04 | −$272.00 | −26,053.8% |
| May 2026 | −$1.33 | −$9.74 | −632.3% |
| Mar 2026 | −$1.80 | −$2.99 | −66.1% |
| Nov 2025 | −$1.60 | −$4.00 | −150.0% |
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Sep 2023 | |||
| Jul 2023 | |||
| Mar 2023 | |||
| Sep 2022 | |||
| Jul 2022 | |||
| May 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Apr 2021 | |||
| Jun 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Oct 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| May 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$2.26 | — | — | $0 | — | — | — |
| Sep 2027 | −$2.29 | — | — | $0 | — | — | — |
| Jun 2027 | −$2.00 | — | — | $0 | — | — | — |
| Mar 2027 | −$2.09 | — | — | $0 | — | — | — |
| Dec 2026 | −$1.52 | — | — | $0 | — | — | — |
| Dec 4, 2026 | −$2.24 | — | — | $0 | — | — | — |
| Aug 13, 2026 | −$1.04 | −$272.00 | −26,053.8% | — | — | — | −2.5% |
| May 19, 2026 | −$1.33 | −$9.74 | −632.3% | — | — | — | −8.3% |
| Mar 30, 2026 | −$1.80 | −$2.99 | −66.1% | — | — | — | −4.2% |
| Nov 13, 2025 | −$1.60 | −$4.00 | −150.0% | — | — | — | +1.7% |
| Aug 13, 2025 | |||||||
| May 15, 2025 | |||||||
| Apr 16, 2025 | |||||||
| Nov 19, 2024 | |||||||
| Aug 19, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Jan 8, 2024 | |||||||
| Oct 10, 2023 | |||||||
| Sep 29, 2023 | |||||||
| Jul 19, 2023 | |||||||
| Mar 13, 2023 | |||||||
| Sep 27, 2022 | |||||||
| Jul 20, 2022 | |||||||
| May 16, 2022 | |||||||
| Dec 3, 2021 | |||||||
| Sep 22, 2021 | |||||||
| Apr 20, 2021 | |||||||
| Jun 29, 2021 | |||||||
| Dec 11, 2020 | |||||||
| Sep 1, 2020 | |||||||
| May 29, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Nov 4, 2019 | |||||||
| Aug 29, 2019 | |||||||
| Apr 23, 2019 | |||||||
| Nov 15, 2018 | |||||||
| Aug 17, 2018 | |||||||
| Mar 21, 2018 | |||||||
| Nov 13, 2017 | |||||||
| Oct 18, 2017 | |||||||
| Aug 10, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 11, 2016 | |||||||
| May 12, 2016 | |||||||
| Mar 23, 2016 | |||||||
| Nov 23, 2015 | |||||||
| Aug 12, 2015 | |||||||
| May 12, 2015 |